A Prescription Digital Therapeutic Framework for Enhancing Medical Cannabis Care

WHY IT MATTERS: Patients using medical cannabis may soon have access to digital tools that help their physicians track symptom changes and adjust treatment more precisely over time. CLINICAL OVERVIEW: The integration of prescription digital therapeutics into cannabinoid medicine represents a meaningful step toward structuring clinical care around measurable outcomes, individualized dosing protocols, and accountable therapeutic frameworks. Digital tools have the potential to capture real-world patient data that traditional clinical encounters often miss, including symptom trajectories, titration responses, and adherence patterns.

Read More

DOH sets conditions on proposed medical cannabis legalization | Philippine News Agency

WHY IT MATTERS: If the Philippines establishes a regulated medical cannabis program, patients in the country who currently have no legal access to cannabinoid therapies for conditions like chronic pain, epilepsy, or cancer-related symptoms could gain physician-supervised treatment options through a formal compassionate access pathway. CLINICAL OVERVIEW: The Philippine Department of Health is establishing conditions for a proposed medical cannabis legalization framework that would include compassionate access pathways for patients alongside expanded research initiatives and formal regulatory oversight. This approach mirrors the structured medical cannabis programs that have been successfully implemented in dozens of countries worldwide, where physician-supervised access is paired with robust safety monitoring.

Read More

Full-Spectrum Cannabis Extract Shows Significant Pain Reduction in Chronic Neuropathic Pain

If you live with chronic nerve pain, this study provides clinical evidence that full-spectrum cannabis extracts can deliver meaningful relief with fewer side effects than many conventional pain medications. A clinical study found that a full-spectrum cannabis extract containing a balanced ratio of THC and CBD produced statistically significant reductions in chronic neuropathic pain compared to placebo. Patients reported meaningful improvements in pain intensity, sleep quality, and overall quality of life with minimal adverse effects.

Read More